Loading...
ESMO congress Lung Cancer 20182025-01-28T17:06:14+01:00

ESMO 2018 – Munich

 

Lecture Board: Maximilian Hochmair, MD; Enriqueta Felip, MD, PhD; Sanjay Popat, PhD, FRCP
Medical Writer: Judith Moser, MD

DOWNLOADS

All downloads from ESMO 2018

ESMO 2018 English

Full report (english)

ESMO 2018 Mandarin

Full report (mandarin)

ESMO 2018 Japanese

Full report (japanese)

EXPERT VIDEOS

All videointerviews from ESMO 2018

Sanjay Popat talks about modern chemotherapeutic treatment options for patients with squamous NSCLC, the benefits of combining immunotherapies with chemotherapy and the use of liquid biopsy for metastatic NSCLC in clinical practice today.

Luis Paz-Ares explains new principles of treatment using bifunctional fusion proteins, their advantages compared to the existing therapies and preliminary results in NSCLC patients.

Approximately 25,000 participants including experts from various oncology disciplines, healthcare policy makers, and patient advocates convened from all over the world to discuss innovations and the major challenge of turning new insights into actual improvements in cancer patient care. Various obstacles of structural and financial nature still tend to impede this process in many countries, and joint efforts need to be put into the task of overcoming them.

Sanjay Popat • PhD • FRCP, Consultant Thoracic Medical Oncologist, Royal Marsden Hospital, London, UK
Go to Top